Home > Balance Sheet > BAL PHARMA

BAL PHARMA
Contingent Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results

BAL PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Contingent Liabilities ₹16 Cr₹16 Cr₹13 Cr₹13 Cr₹20 Cr

What is the latest Contingent Liabilities ratio of BAL PHARMA ?

The latest Contingent Liabilities ratio of BAL PHARMA is ₹16 Cr based on Mar2023 Consolidated results.
Year Contingent Liabilities
Mar2023₹16 Cr
Mar2022₹16 Cr
Mar2021₹13 Cr
Mar2020₹13 Cr
Mar2019₹20 Cr

How is Contingent Liabilities of BAL PHARMA Trending?

Years Contingent Liabilities % Change
Mar2023 ₹16 Cr
1.18
Mar2022 ₹16 Cr
25.01
Mar2021 ₹13 Cr
0.00
Mar2020 ₹13 Cr
-35.95
Mar2019 ₹20 Cr -

Compare Contingent Liabilities of peers of BAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BAL PHARMA ₹157.7 Cr -3% -1.1% 17.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹356,673.0 Cr -2.9% 0% 59.6% Stock Analytics
CIPLA ₹119,930.0 Cr 5.8% 6.2% 60.9% Stock Analytics
DIVIS LABORATORIES ₹109,446.0 Cr 5% 8% 25.9% Stock Analytics
ZYDUS LIFESCIENCES ₹108,261.0 Cr -2.6% 15.3% 114.4% Stock Analytics
DR REDDYS LABORATORIES ₹97,830.6 Cr 0.9% -1.5% 32.2% Stock Analytics


BAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BAL PHARMA

-3%

-1.1%

17.9%

SENSEX

2%

2.3%

22.2%


You may also like the below Video Courses